
Foraco International SA (TSE:FAR – Free Report) – Stock analysts at Clarus Securities cut their Q2 2027 earnings per share (EPS) estimates for Foraco International in a report released on Friday, October 30th. Clarus Securities analyst S. Kammermayer now expects that the company will post earnings of $0.13 per share for the quarter, down from their prior forecast of $0.14. The consensus estimate for Foraco International’s current full-year earnings is $0.60 per share. Clarus Securities also issued estimates for Foraco International’s FY2027 earnings at $0.41 EPS.
Foraco International Stock Up 3.2%
Shares of TSE:FAR opened at C$2.29 on Tuesday. The company has a quick ratio of 0.88, a current ratio of 1.21 and a debt-to-equity ratio of 99.68. The company has a market capitalization of C$224.08 million, a P/E ratio of 18.62 and a beta of 1.56. Foraco International has a 52-week low of C$1.90 and a 52-week high of C$3.54. The stock’s fifty day simple moving average is C$2.64 and its 200-day simple moving average is C$2.79.
Insider Buying and Selling
In related news, Director Daniel Louis Simoncini sold 2,000,000 shares of the business’s stock in a transaction dated Wednesday, September 9th. The shares were sold at an average price of C$3.02, for a total value of C$6,040,000.00. Following the completion of the transaction, the director owned 8,571,225 shares of the company’s stock, valued at approximately C$25,885,099.50. The trade was a 18.92% decrease in their position. Corporate insiders own 35.74% of the company’s stock.
Foraco International Company Profile
Foraco International SA (TSX: FAR) is a leading global mineral drilling services company that provides a comprehensive and reliable service offering in mining and water projects. Supported by its founding values of integrity, innovation and involvement, Foraco has grown into the third largest global drilling enterprise with a presence in 16 countries across five continents.
Recommended Stories
- Five stocks we like better than Foraco International
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AIāThese 5 Stocks Are Getting Paid
Receive News & Ratings for Foraco International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Foraco International and related companies with MarketBeat.com's FREE daily email newsletter.
